-
公开(公告)号:CA2785931A1
公开(公告)日:2011-07-21
申请号:CA2785931
申请日:2011-01-13
Applicant: UCB PHARMA SA
Inventor: ELLIS MARK , HUMPHREYS DAVID PAUL
IPC: C12N1/21 , C07K16/24 , C12N9/48 , C12N9/90 , C12N15/00 , C12N15/57 , C12N15/63 , C12N15/70 , C12P21/02
Abstract: The present invention provides a recombinant gram-negative bacterial cell comprising a mutant spr gene encoding a mutant spr protein and wherein the cell comprises a non-recombinant wild-type chromosomal Tsp gene.
-
公开(公告)号:AU2006298590A1
公开(公告)日:2007-04-12
申请号:AU2006298590
申请日:2006-09-29
Applicant: UCB PHARMA SA
Inventor: HUMPHREYS DAVID PAUL , ELLIS MARK
Abstract: The present invention provides a dicistronic message for producing an antibody molecule, in which the upstream cistron contains DNA coding for the light chain of the antibody and the downstream cistron contains DNA coding for the corresponding heavy chain, characterised in that the dicistronic message comprises a sequence selected from AEOS1 (SEQ ID NO:1), AEOS2 (SEQ ID NO:2), AEOS3 (SEQ ID NO:3), AEOS4 (SEQ ID NO: 4), AEOS5 (SEQ ID NO:5), AEOS6 (SEQ ID NO:6), AEOS7 (SEQ ID NO:7), AEOS8 (SEQ ID NO:8), AEOS9 (SEQ ID NO:9), AEOS1O (SEQ ID NO:10) and AEOS11 (SEQ ID NO:11).
-
公开(公告)号:CA2841824C
公开(公告)日:2021-07-13
申请号:CA2841824
申请日:2012-07-13
Applicant: UCB PHARMA SA
Inventor: ELLIS MARK , HUMPHREYS DAVID PAUL
Abstract: The present invention relates to the development of a bacterial periplasmic system for expressing antibodies. Specifically there is provided a recombinant gram-negative bacterial cell comprising: a mutated Tsp gene which is a knockout mutated Tsp gene or which encodes a Tsp protein having reduced protease activity compared to a wild type Tsp gene, a mutated spr gene encoding an spr protein capable of suppressing the growth phenotype of a cell comprising a mutated Tsp phenotype, an expression vector comprising a recombinant polynucleotide encoding DsbC; and one or more polynucleotides encoding an antibody or an antigen binding fragment thereof specifically binding to CD154.
-
公开(公告)号:CA2774692C
公开(公告)日:2017-12-19
申请号:CA2774692
申请日:2010-09-23
Applicant: UCB PHARMA SA
Inventor: ELLIS MARK , HUMPHREYS DAVID PAUL
Abstract: A recombinant gram-negative bacterial cell comprising one or more of the following mutated protease genes: a. a mutated Tsp gene, wherein the mutated Tsp gene encodes a Tsp protein having reduced protease activity or is a knockout mutated Tsp gene; b. a mutated ptr gene, wherein the mutated ptr gene encodes a Protease III protein having reduced protease activity or is a knockout mutated ptr gene; and c. a mutated DegP gene encoding a DegP protein having chaperone activity and reduced protease activity; wherein the cell is isogenic to a wild-type bacterial cell except for the mutated Tsp gene and/or mutated ptr gene and/or mutated Deg P gene and optionally a polynucleotide sequence encoding a protein of interest.
-
公开(公告)号:AU2012283388B2
公开(公告)日:2017-04-20
申请号:AU2012283388
申请日:2012-07-13
Applicant: UCB PHARMA SA
Inventor: ELLIS MARK , HUMPHREYS DAVID PAUL
Abstract: The present invention provides a recombinant gram-negative bacterial cell comprising an expression vector, comprising a recombinant polynucleotide encoding DsbC and one or more polynucleotides encoding an antibody or an antigen binding fragment thereof specifically binding to CD154.
-
公开(公告)号:AU2011206584B2
公开(公告)日:2016-06-09
申请号:AU2011206584
申请日:2011-01-13
Applicant: UCB PHARMA SA
Inventor: ELLIS MARK , HUMPHREYS DAVID PAUL
IPC: C12N15/70 , C07K14/245
Abstract: The present invention provides a recombinant gram-negative bacterial cell comprising a mutant spr gene encoding a spr protein having a mutation at one or more amino acids selected from D133, H145, H157, N31, R62, 170, Q73, C94, S95, V98, Q99, R100, L108, Y115, V135, L136, G140, R144 and G147 and wherein the cell has reduced Tsp protein activity compared to a wild-type cell.
-
37.
公开(公告)号:BR112012017425A2
公开(公告)日:2015-09-15
申请号:BR112012017425
申请日:2011-01-13
Applicant: UCB PHARMA SA
Inventor: HUMPHREYS DAVID PAUL , ELLIS MARK
IPC: C07K14/245 , C12N15/70
Abstract: cepa hospedeira bacteriana compreendendo um gene spr mutante e tendo atividade tsp reduzida. a presente invenção fornece uma célula bacteriana gram negativa recombinante que compreende um gene spr mutante que codifica uma proteína spr tendo uma mutação em um ou mais aminoácidos selecionados de d133, h145, h157, n31, r62, i70, q73, c94,s95, v98, r100, l108, y115, v135, l136, g140, r144 e g147 e em que a célula possui atividade de proteína tsp reduzida comparada com uma célula do tipo selvagem.
-
">
公开(公告)号:IN2401DEN2012A
公开(公告)日:2015-08-21
申请号:IN2401DEN2012
申请日:2012-03-20
Applicant: UCB PHARMA SA
Inventor: ELLIS MARK , HUMPHREYS DAVID PAUL
IPC: C12N9/50
Abstract: A recombinant gram-negative bacterial cell comprising one or more of the following mutated protease genes: a. a mutated Tsp gene, wherein the mutated Tsp gene encodes a Tsp protein having reduced protease activity or is a knockout mutated Tsp gene; b. a mutated ptr gene, wherein the mutated ptr gene encodes a Protease III protein having reduced protease activity or is a knockout mutated ptr gene; and c. a mutated DegP gene encoding a DegP protein having chaperone activity and reduced protease activity ; wherein the cell is isogenic to a wild-type bacterial cell except for the mutated Tsp gene and/or mutated ptr gene and/or mutated Deg P gene and optionally a polynucleotide sequence encoding a protein of interest.
-
公开(公告)号:SG182280A1
公开(公告)日:2012-08-30
申请号:SG2012047676
申请日:2011-01-13
Applicant: UCB PHARMA SA
Inventor: ELLIS MARK , HUMPHREYS DAVID PAUL
Abstract: The present invention provides a recombinant gram-negative bacterial cell, characterized in that the cell: a. comprises a recombinant polynucleotide encoding DsbC; and b. has reduced Tsp protein activity compared to a wild-type cell.
-
-
-
-
-
-
-
-